Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.
- 1 July 1995
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 32 (7) , 543-545
- https://doi.org/10.1136/jmg.32.7.543
Abstract
The factor V Leiden variant, responsible for the phenomenon of activated protein C resistance, was found to be less frequent among British (0.06) and Swedish/Danish (0.15) protein C deficiency patients than previously reported in a Dutch study (0.19). In the Swedish population, a significantly increased frequency of the factor V Leiden allele was apparent in protein C deficiency patients as compared to healthy controls. However, this was not found in the British population. Coinheritance of the factor V Leiden variant is therefore unlikely to be the sole determinant of whether a person with protein C deficiency will come to clinical attention. Nevertheless, when patient data were analysed by type of protein C deficiency, it was noted that the frequency of the factor V Leiden variant was 2.8-fold higher in type II patients compared to type I patients. A possible explanation of this disparity is discussed.Keywords
This publication has 14 references indexed in Scilit:
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Inherited resistance to activated protein C iscorrected by anticoagulant cofactor activity found to be a property of factorV.Proceedings of the National Academy of Sciences, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defectThe Lancet, 1993
- Absence of Thrombosis in Subjects with Heterozygous Protein C DeficiencyNew England Journal of Medicine, 1987
- Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.Proceedings of the National Academy of Sciences, 1985
- Outline of Genetic Epidemiology.Published by JSTOR ,1983